ArticleTranslational cancer research2026
Venous thromboembolism risk in sarcoma patients receiving combined immune checkpoint inhibitors and VEGF pathway inhibitors: a real-world cohort study.
Rahul Kumar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.